Beyond its crucial role in supplying cholesterol, we investigated whether the cell-surface LDLR, which we find also highly expressed in patient PDAC and metastases, may constitute a promising target candidate to ensure specific tumor-targeting. This evidence concerns the gene LDLR and neoplasm.